NCT06445894 · NOT YET RECRUITING
Accelerated Intermittent Theta-burst Stimulation to Modify Cognitive Function and Balance in Dementia and Memory Loss
This trial is testing a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation, or rTMS, in people already diagnosed with dementia or memory loss. Researchers want to know whether stimulating one brain region improves balance more than stimulating another. It is a Phase NA study, meaning it is a clinical trial focused on comparing two device approaches rather than a standard drug-efficacy phase.
You may qualify if
- Individuals must be diagnosed with Dementia and/or memory loss by a clinician.
- Individuals must exhibit adequate oral communication skills and cognitive function sufficient to obtain a score ranging between 10-27 on the Mini-Mental State Exam (Wu et al., 2022).
- Instructions will be delivered in English; therefore participants must demonstrate an understanding of instruction provided in English or have a caregiver present who can translate and be presented during all study sessions.
- Individuals must be able to walk or stand with or without personnel or assistive devices.
- Individuals must be greater than or equal to 50 years of age.
You're excluded if
- 1. Contraindications to rTMS; presence of a pacemaker, metal/electrical/magnetic implants not including titanium, known history of untreated or uncontrolled psychological disorders, pregnancy, history of seizure or diagnoses of epilepsy, are taking any prescription medications that increase the risk of seizure.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-06-06